[go: up one dir, main page]

PT964856E - Aminoacidos aromaticos biciclicos - Google Patents

Aminoacidos aromaticos biciclicos

Info

Publication number
PT964856E
PT964856E PT98908063T PT98908063T PT964856E PT 964856 E PT964856 E PT 964856E PT 98908063 T PT98908063 T PT 98908063T PT 98908063 T PT98908063 T PT 98908063T PT 964856 E PT964856 E PT 964856E
Authority
PT
Portugal
Prior art keywords
amino acids
aromatic amino
bacterial aromatic
bacterial
acids
Prior art date
Application number
PT98908063T
Other languages
English (en)
Inventor
Rippmann Dr Friedrich
Simon Goodman
Raddatz Dr Peter
Beate Diefenbach
Joachim Marz
Matthias Wiesner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT964856E publication Critical patent/PT964856E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98908063T 1997-02-13 1998-02-06 Aminoacidos aromaticos biciclicos PT964856E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19705450A DE19705450A1 (de) 1997-02-13 1997-02-13 Bicyclische aromatische Aminosäuren

Publications (1)

Publication Number Publication Date
PT964856E true PT964856E (pt) 2003-02-28

Family

ID=7820093

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98908063T PT964856E (pt) 1997-02-13 1998-02-06 Aminoacidos aromaticos biciclicos

Country Status (25)

Country Link
EP (1) EP0964856B1 (pt)
JP (1) JP4327257B2 (pt)
KR (1) KR20000071030A (pt)
CN (1) CN1085205C (pt)
AR (1) AR010894A1 (pt)
AT (1) ATE225776T1 (pt)
AU (1) AU735313B2 (pt)
BR (1) BR9807345A (pt)
CA (1) CA2280727C (pt)
CY (1) CY2341B1 (pt)
CZ (1) CZ297366B6 (pt)
DE (2) DE19705450A1 (pt)
DK (1) DK0964856T3 (pt)
ES (1) ES2183332T3 (pt)
HU (1) HUP0001138A3 (pt)
ID (1) ID22533A (pt)
NO (1) NO313289B1 (pt)
PL (1) PL335101A1 (pt)
PT (1) PT964856E (pt)
RU (1) RU2187506C2 (pt)
SI (1) SI0964856T1 (pt)
SK (1) SK284646B6 (pt)
TR (1) TR199901962T2 (pt)
WO (1) WO1998035949A1 (pt)
ZA (1) ZA981178B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063790A1 (en) * 1996-05-31 2004-04-01 The Scripps Research Institute Methods for inhibition of angiogenesis
ATE542797T1 (de) 1998-04-09 2012-02-15 Meiji Seika Pharma Co Ltd Aminopiperidinderivate als integrin alpha v beta 3 antagonisten
PL351279A1 (en) 1999-04-13 2003-04-07 Abbott Gmbh & Co Kg Integrin receptor ligands
AU6316900A (en) 1999-08-05 2001-03-05 Meiji Seika Kaisha Ltd. Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism
EP1244616A1 (en) * 1999-12-24 2002-10-02 SmithKline Beecham plc (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
DE60101351T2 (de) * 2000-01-25 2004-10-07 Kaneka Corp Verfahren zur herstellung optisch aktiver, n-substituierter azetidin-2-carbonsäuren
CN100571772C (zh) * 2000-11-01 2009-12-23 默克专利有限公司 整联蛋白受体αvβ3和/或αvβ5的拮抗剂在制备用于治疗眼疾的药物中的用途
ATE415163T1 (de) * 2000-11-01 2008-12-15 Merck Patent Gmbh Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
EP1404860B8 (en) 2001-05-30 2013-12-25 The Scripps Research Institute Delivery system for nucleic acids
HUP0401605A3 (en) 2001-08-01 2012-09-28 Merck Patent Gmbh Integrin inhibitors for the treatment of eye diseases
RU2004127577A (ru) * 2002-02-14 2005-05-27 Мерк Патент ГмбХ (DE) Способы и композиции для лечения заболеваний глаз
FR2847254B1 (fr) * 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
DE10305784A1 (de) * 2003-02-12 2004-08-26 Merck Patent Gmbh Verfahren zur Herstellug bicyclischer aromatischer Aminosäuren sowie deren Zwischenprodukte
DE10337863A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
EP2484364B1 (en) * 2004-06-04 2014-02-19 The Scripps Research Institute Compositions for treatment of neovascular diseases
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
PL2380881T3 (pl) * 2008-12-26 2017-07-31 Sumitomo Dainippon Pharma Co., Ltd. Nowy bicykliczny związek heterocykliczny
WO2011024987A1 (ja) * 2009-08-31 2011-03-03 塩野義製薬株式会社 芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物
AR090259A1 (es) 2012-03-06 2014-10-29 Boehringer Ingelheim Int Inhibidores de benzodioxano de la produccion de leucotrieno para terapia de combinacion
TW201416354A (zh) 2012-07-17 2014-05-01 Boehringer Ingelheim Int 白三烯生成抑制劑
EP3022194B1 (en) 2013-07-15 2017-05-17 Boehringer Ingelheim International GmbH Inhibitors of leukotriene production
WO2015009609A1 (en) 2013-07-15 2015-01-22 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
MX2016015467A (es) 2014-05-30 2017-03-23 Pfizer Derivados de carbonitrilo como moduladores selectivos del receptor de androgenos.
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
CA3221177A1 (en) 2021-11-01 2023-05-04 Meghan Kerrisk Campbell Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3151690A1 (de) * 1981-12-29 1983-07-07 Hoechst Ag, 6230 Frankfurt "neue derivate bicyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung"
FR2674854B1 (fr) * 1991-04-04 1995-03-03 Bouchara Nouvelles quinolones leur procede de preparation et les compositions pharmaceutiques en refermant.
US5648368A (en) * 1992-12-01 1997-07-15 Merck & Co., Inc. Fibrinogen receptor antagonists
DE69528829T2 (de) * 1994-05-27 2003-08-07 Merck & Co., Inc. Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
DE19548709A1 (de) * 1995-12-23 1997-07-03 Merck Patent Gmbh Tyrosinderivate
DE19654483A1 (de) * 1996-06-28 1998-01-02 Merck Patent Gmbh Phenylalanin-Derivate
EP0907637A1 (de) * 1996-06-28 1999-04-14 MERCK PATENT GmbH Phenylalanin-derivate als integrin-inhibitoren

Also Published As

Publication number Publication date
CN1085205C (zh) 2002-05-22
SI0964856T1 (en) 2003-04-30
HUP0001138A3 (en) 2002-10-28
DE19705450A1 (de) 1998-08-20
ID22533A (id) 1999-10-28
AU735313B2 (en) 2001-07-05
WO1998035949A1 (de) 1998-08-20
RU2187506C2 (ru) 2002-08-20
SK284646B6 (sk) 2005-08-04
EP0964856B1 (de) 2002-10-09
PL335101A1 (en) 2000-04-10
NO313289B1 (no) 2002-09-09
NO993901L (no) 1999-10-12
HUP0001138A2 (hu) 2001-05-28
JP2001511789A (ja) 2001-08-14
DK0964856T3 (da) 2003-02-10
ES2183332T3 (es) 2003-03-16
ATE225776T1 (de) 2002-10-15
CY2341B1 (en) 2004-02-06
CA2280727C (en) 2008-05-06
AU6620698A (en) 1998-09-08
DE59805895D1 (de) 2002-11-14
AR010894A1 (es) 2000-07-12
JP4327257B2 (ja) 2009-09-09
SK107199A3 (en) 2000-05-16
CN1252064A (zh) 2000-05-03
BR9807345A (pt) 2000-03-21
CZ297366B6 (cs) 2006-11-15
EP0964856A1 (de) 1999-12-22
CA2280727A1 (en) 1998-08-20
NO993901D0 (no) 1999-08-12
TR199901962T2 (xx) 1999-12-21
KR20000071030A (ko) 2000-11-25
ZA981178B (en) 1999-05-21
CZ287599A3 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
PT964856E (pt) Aminoacidos aromaticos biciclicos
ATE238984T1 (de) Sulfonylaminocarbonsäuren
DE69837776D1 (de) Etiketten
NO985680D0 (no) Peptidderivater
DK0904288T3 (da) Patogent Escherichia coli-associeret protein
NO983849L (no) Peptidderivater
AU6760798A (en) Bax inhibitor proteins
EP1018551A4 (en) MEGSIN PROTEIN
EE9900445A (et) Bakteriaalsed plasmiidid
TR199701666A3 (tr) Sismanliga karsi proteinler
KR970052661U (ko) 라벨
DE69802830D1 (de) Aromatische substituierte naphtopyranen
SE9602844D0 (sv) Amino acid conjugate
DK1017798T3 (da) Lunasinpeptider
IL122435A0 (en) Amino butyric acids fungicides
NO20000976D0 (no) Peptider
GB9704252D0 (en) Novel protein
GB9703850D0 (en) Novel protein
GB9703827D0 (en) Novel protein
GB9706119D0 (en) Novel protein
UA1739S (uk) Етикетка
UA1760S (uk) Етикетка
UA1723S (uk) Етикетка
UA1724S (uk) Етикетка
UA1761S (uk) Етикетка